ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Allogene Therapeutics (ALLO) Technical (Analysis) Reports Allogene Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Allogene Therapeutics (ALLO)

Technical Analysis Report for NASDAQ stock ALLO Allogene Therapeutics. Dated: 30 Oct 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock ALLO Allogene Therapeutics then click here. or read Experts views on Allogene Therapeutics or Forecast & share price targets of Allogene Therapeutics

Allogene Therapeutics Opened at 1.25 and Closed at: 1.17, which is -7.69% of previous session's close. It moved within a range of 1.16 and 1.26
The session was a Bearish session with an average volume of 8617045, which is 23.46% of previous session's volumes.

  • The stock has fallen, and its short term trend is also negative and in a downtrend.
  • The stock has fallen, and its mid term trend is also negative and in a downtrend.

Support for tomorrow is 1.12 and resistance for tomorrow is 1.22
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 1.13, 1.1 resistance for tomorrow's hourly charts is 1.23, 1.3

10 Day SMA for Allogene Therapeutics (ALLO) is 1.26 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Allogene Therapeutics (ALLO) is 1.33 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Allogene Therapeutics (ALLO) is 1.62 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 1.79 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Allogene Therapeutics is 1.98 and stock is trading below these levels. This is not a good sign for its long term trend

20 DMA of Allogene Therapeutics is at 1.33 and 200 DMA is at 1.98, while 50 DMA and 100 DMA are at 1.62 and 1.79 respectively

Allogene Therapeutics (ALLO) moving average of 20 SMA is at 1.33 and 20 EMA is at 1.33

Allogene Therapeutics (ALLO) moving average of 50 SMA is at 1.62 and 50 EMA is at 1.55

Allogene Therapeutics (ALLO) moving average of 100 SMA is at 1.79 and 100 EMA is at 1.66

Allogene Therapeutics (ALLO) moving average of 200 SMA is at 1.98 and 200 EMA is at 1.75

Tandem Diabetes has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Tandem Diabetes, about 37.68% more returns!

Allogene Therapeutics has performed better than Sutro Biopharma in short term. Holding Allogene Therapeutics could be a better choice for now!

Allogene Therapeutics has performed better than Syndax Pharmaceuticals in short term. Holding Allogene Therapeutics could be a better choice for now!

Pro Dex has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Pro Dex, about 10.93% more returns!

Addus Homecare has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Addus Homecare, about 33.12% more returns!

Array Biopharma has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Array Biopharma, about 8.96% more returns!

Allogene Therapeutics has performed better than Anavex Life in short term. Holding Allogene Therapeutics could be a better choice for now!

Audentes Therapeutics has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Audentes Therapeutics, about 17% more returns!

Caredx Inc has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Caredx Inc, about 47.03% more returns!

Eloxx Pharmaceuticals has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Eloxx Pharmaceuticals, about 9.28% more returns!

National Vision has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in National Vision, about 22.42% more returns!

Idexx Laboratories has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Idexx Laboratories, about 26.58% more returns!

Allogene Therapeutics has performed better than Iovance Biotherapeutics in short term. Holding Allogene Therapeutics could be a better choice for now!

Mesoblast has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Mesoblast, about 28.69% more returns!

Allogene Therapeutics Technical analysis of indicators

Price action analysis of Allogene Therapeutics (ALLO) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small

ADX buy sell signal for Allogene Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.

MACD generated a BUY signal for Allogene Therapeutics in short term but the buy signal is initial and weak.

Allogene Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down

CCI has generated a SELL signal for Allogene Therapeutics in short term and SELL signal is strong!

RSI is generating a SELL signal in short term and selling is picking up momentum.

MRSI is in positive zone. This is a BUY zone

Stock of Allogene Therapeutics is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 1.25 and Allogene Therapeutics ALLO stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the Allogene Therapeutics ALLO stock. Volume based technical analysis of Allogene Therapeutics ALLO stock is negative.

Allogene Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock ALLO Allogene Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And ALLO Experts View which covers a lot of information including buying and selling signals

ALLO future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Allogene Therapeutics or View Candle Stick Charts here

Chart Allogene Therapeutics (ALLO)  Technical (Analysis) Reports Allogene Therapeutics [

Videos related to: Allogene Therapeutics (ALLO) Technical (Analysis) Reports Allogene Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Allogene Therapeutics (ALLO)  Technical (Analysis) Reports Allogene Therapeutics [

 

Back to top